- Oncolytics Biotech (ONCY, Financial) will host its Q1 2025 earnings call on May 14, 2025, at 4:30 p.m. ET.
- The call will cover financial results and a corporate update, with access via toll-free and international lines.
- A webcast replay will be available for three months, with a dial-in replay accessible for one week.
Oncolytics Biotech Inc. (NASDAQ: ONCY), a clinical-stage company specializing in immunotherapy for oncology, has announced that it will hold a conference call and webcast to discuss its first-quarter financial results for 2025. This event is scheduled for Wednesday, May 14, 2025, at 4:30 p.m. Eastern Time.
Participants can join the call through the North American toll-free number (888) 510-2154 or the international line (437) 900-0527, using conference ID 28038. Additionally, the call will be available as a webcast on Oncolytics' Investor Relations page and will be archived for three months.
The company is advancing its immunotherapeutic agent, pelareorep, which has shown promising results in metastatic breast cancer and pancreatic cancer studies. Oncolytics plans to conduct further trials in these and other cancer types, with ongoing efforts towards registration studies in both metastatic breast cancer and pancreatic cancer, which have received Fast Track designation from the FDA.
For more information, please visit Oncolytics Biotech's website at www.oncolyticsbiotech.com.
